Black Women Have Worse IVF Outcomes Versus White Women

This article originally appeared here.
Share this content:
Black Women Have Worse IVF Outcomes Versus White Women
Black Women Have Worse IVF Outcomes Versus White Women

THURSDAY, Feb. 18, 2016 (HealthDay News) -- Black women have worse in vitro fertilization (IVF) outcomes than white women, according to a review published in the February issue of the American Journal of Obstetrics & Gynecology.

Leigh A. Humphries, from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a systematic literature search to identify studies that compared clinical pregnancy rates and live birth rates for more than two racial and/or ethnic groups after non-donor IVF cycles.

The researchers identified 24 studies. Based on the five U.S. registry-based studies, black, Hispanic, and Asian women had lower clinical pregnancy rates and/or live birth rates after IVF, compared with white women. Significant disparities in these primary outcomes were similarly seen in clinic-specific studies, potentially attributable to differences in infertility diagnosis, spontaneous abortion, and obesity. Definitions of race/ethnicity, inclusion of first cycles versus multiple cycles for individual women, and collected covariates varied between studies. Limitations of studies included sample size, inadequate adjustment for confounding, selection bias, and extensive missing data.

"Although current evidence points to race and ethnicity, especially black race, as strong predictors of poorer outcomes after IVF, the utility of results is constrained by the limitations described," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths